MedPath

To assess whether desmopressin reduces complications in patients with kidney dysfunction undergoing renal biopsy

Phase 3
Conditions
Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)
Registration Number
CTRI/2022/03/041038
Lead Sponsor
PGIMER research GRANT
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. eGFR less than 45 ml per minute.

2. Those who give informed consent.

Exclusion Criteria

Pregnancy

Post renal transplant patient

Uncontrolled hypertension

Haemoglobin < 8 gm/dl

Platelet count < 85,000/μL

Active bleeding

Evidence of active urinary tract infection

Diagnosis of a congenital abnormality of

kidneys or urinary tract

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath